Sanofi to acquire mRNA therapeutics firm Translate Bio for $3.2bn
The acquisition of Translate Bio will help French drugmaker Sanofi to further advance the development of transformative medicines…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 21
The acquisition of Translate Bio will help French drugmaker Sanofi to further advance the development of transformative medicines…
03 Aug 21
Moderna will make an upfront payment for each target it licensed from Autolus, in addition to milestone payments…
27 Jul 21
The acquisition of BioLegend, the largest transaction in PerkinElmer’s history, will expand its existing life science franchise into…
15 Jul 21
In a previous equity investment round, Lilly acquired a 14% stake in California-based Promoter
18 Jun 21
Upon closing of the transaction, Aldevron will operate as an individual company and a brand operating within Danaher's…
05 Jan 21
The new facility, to be located in Watertown, Massachusetts, will manufacture viral vectors and advanced therapies
05 Nov 20
The partnership will develop advanced analytical solutions and deliver training to address the current requirements of the biopharmaceutical…
PharmaceuticalsConsulting, Training and Other Pharmaceutical Services
08 Sep 20
Alkahest is a wholly-owned subsidiary within the Grifols innovation office (GIANT) and is focused on proteins with a…
28 Aug 20
IMO is a rare, severe autosomal recessive disorder is caused due to mutations in the TCIRG1 gene, which…
25 Aug 20
Forbius develops a portfolio of selective potent inhibitors of TGF-beta 1 & 3, which mediate immunosuppression and fibrosis